Literature DB >> 6648790

The acromegaly--gigantism syndrome. Report of four cases treated surgically.

P Zampieri, M Scanarini, N Sicolo, G Andrioli, S Mingrino.   

Abstract

Four cases of growth-hormone-secreting pituitary adenoma, with associated aspects of acromegaly and gigantism, are reported in patients aged 12-26. All of the patients had macroadenomas and were treated surgically, three by the transsphenoidal approach and one with a transfrontal craniotomy. Histologic examination revealed eosinophilic adenomas in three of the cases and a mixed eosinophilic--chromophobe adenoma in one, all with cellular irregularities (mitosis and cellular and nuclear polymorphism), local invasivity, or both. Because surgical treatment did not produce complete normalization of growth hormone levels, radiotherapy followed the operations in all four cases. In our opinion, the treatment of acromegalic gigantism poses more therapeutic problems than that of simple acromegaly, with combined treatment (surgical, radiation, and medical) often being necessary.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6648790     DOI: 10.1016/0090-3019(83)90034-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child.

Authors:  J Flitsch; D K Lüdecke; N Stahnke; J Wiebel; W Saeger
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

2.  Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant.

Authors:  Naila Goldenberg; Michael S Racine; Pamela Thomas; Bernard Degnan; William Chandler; Ariel Barkan
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

3.  Pathological and experimental investigations in a case of gigantism.

Authors:  I Fazekas; E Pásztor; F Slowik; K Bálint; I Dobronyi; E Bácsy; A Gyévai; F Péter; L Blatniczky; I Varga
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  The Pituitary in Gigantism.

Authors:  Bernd W. Scheithauer; Kalman T. Kovacs; Lucia Stefaneanu; Eva Horvath; Laurie A. Kane; William F. Young; Ricardo V. Lloyd; Raymond V. Randall; Dudley H. Davis
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

5.  Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.

Authors:  I A Felix; E Horvath; K Kovacs; H S Smyth; D W Killinger; J Vale
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.